nodes	percent_of_prediction	percent_of_DWPC	metapath
Mometasone—Folliculitis—Sorafenib—liver cancer	0.023	0.0348	CcSEcCtD
Mometasone—Secondary infection—Epirubicin—liver cancer	0.0182	0.0275	CcSEcCtD
Mometasone—Dysphonia—Sorafenib—liver cancer	0.0176	0.0266	CcSEcCtD
Mometasone—Endocrine disorder—Sorafenib—liver cancer	0.0174	0.0264	CcSEcCtD
Mometasone—Secondary infection—Doxorubicin—liver cancer	0.0168	0.0254	CcSEcCtD
Mometasone—Sensitisation—Epirubicin—liver cancer	0.015	0.0226	CcSEcCtD
Mometasone—Influenza like illness—Sorafenib—liver cancer	0.014	0.0212	CcSEcCtD
Mometasone—Sensitisation—Doxorubicin—liver cancer	0.0138	0.0209	CcSEcCtD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—TAT—liver cancer	0.0132	0.0397	CbGpPWpGaD
Mometasone—Leukoderma—Epirubicin—liver cancer	0.0126	0.019	CcSEcCtD
Mometasone—Furunculosis—Epirubicin—liver cancer	0.0126	0.019	CcSEcCtD
Mometasone—Furunculosis—Doxorubicin—liver cancer	0.0116	0.0176	CcSEcCtD
Mometasone—Leukoderma—Doxorubicin—liver cancer	0.0116	0.0176	CcSEcCtD
Mometasone—Furuncle—Epirubicin—liver cancer	0.0109	0.0165	CcSEcCtD
Mometasone—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—liver cancer	0.0104	0.0314	CbGpPWpGaD
Mometasone—Furuncle—Doxorubicin—liver cancer	0.0101	0.0152	CcSEcCtD
Mometasone—NR3C1—Nuclear Receptors—NR1I3—liver cancer	0.00958	0.0288	CbGpPWpGaD
Mometasone—Nasopharyngitis—Sorafenib—liver cancer	0.00938	0.0142	CcSEcCtD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—CPT1B—liver cancer	0.00898	0.027	CbGpPWpGaD
Mometasone—CYP2C8—CYP2E1 reactions—CYP2E1—liver cancer	0.00882	0.0265	CbGpPWpGaD
Mometasone—Folliculitis—Epirubicin—liver cancer	0.0085	0.0128	CcSEcCtD
Mometasone—Oral candidiasis—Epirubicin—liver cancer	0.00841	0.0127	CcSEcCtD
Mometasone—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—liver cancer	0.00818	0.0246	CbGpPWpGaD
Mometasone—Folliculitis—Doxorubicin—liver cancer	0.00786	0.0119	CcSEcCtD
Mometasone—Oral candidiasis—Doxorubicin—liver cancer	0.00778	0.0118	CcSEcCtD
Mometasone—NR3C1—Nuclear Receptor transcription pathway—NR1H4—liver cancer	0.0077	0.0231	CbGpPWpGaD
Mometasone—Epistaxis—Sorafenib—liver cancer	0.00763	0.0115	CcSEcCtD
Mometasone—NR3C1—Nuclear Receptor transcription pathway—NR1I3—liver cancer	0.00757	0.0227	CbGpPWpGaD
Mometasone—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—liver cancer	0.00744	0.0224	CbGpPWpGaD
Mometasone—Haemoptysis—Epirubicin—liver cancer	0.00722	0.0109	CcSEcCtD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALDOB—liver cancer	0.00694	0.0209	CbGpPWpGaD
Mometasone—Otitis media—Epirubicin—liver cancer	0.00686	0.0104	CcSEcCtD
Mometasone—Haemoptysis—Doxorubicin—liver cancer	0.00668	0.0101	CcSEcCtD
Mometasone—NR3C1—Nuclear Receptors—HNF4A—liver cancer	0.00664	0.0199	CbGpPWpGaD
Mometasone—Stinging—Epirubicin—liver cancer	0.00659	0.00997	CcSEcCtD
Mometasone—Immune system disorder—Sorafenib—liver cancer	0.00656	0.00991	CcSEcCtD
Mometasone—Mediastinal disorder—Sorafenib—liver cancer	0.00654	0.00989	CcSEcCtD
Mometasone—Dysphonia—Epirubicin—liver cancer	0.00649	0.00982	CcSEcCtD
Mometasone—Otitis media—Doxorubicin—liver cancer	0.00635	0.0096	CcSEcCtD
Mometasone—Stinging—Doxorubicin—liver cancer	0.0061	0.00922	CcSEcCtD
Mometasone—Dysphonia—Doxorubicin—liver cancer	0.00601	0.00908	CcSEcCtD
Mometasone—Viral infection—Epirubicin—liver cancer	0.00591	0.00894	CcSEcCtD
Mometasone—Skin discolouration—Epirubicin—liver cancer	0.00591	0.00894	CcSEcCtD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—HNF4A—liver cancer	0.0059	0.0177	CbGpPWpGaD
Mometasone—Angioedema—Sorafenib—liver cancer	0.00577	0.00873	CcSEcCtD
Mometasone—Ulcer—Epirubicin—liver cancer	0.00565	0.00854	CcSEcCtD
Mometasone—Cough—Sorafenib—liver cancer	0.00551	0.00834	CcSEcCtD
Mometasone—Skin discolouration—Doxorubicin—liver cancer	0.00547	0.00827	CcSEcCtD
Mometasone—Viral infection—Doxorubicin—liver cancer	0.00547	0.00827	CcSEcCtD
Mometasone—CYP2C8—Xenobiotics—CYP2E1—liver cancer	0.00547	0.0164	CbGpPWpGaD
Mometasone—Musculoskeletal pain—Epirubicin—liver cancer	0.00541	0.00817	CcSEcCtD
Mometasone—Myalgia—Sorafenib—liver cancer	0.00538	0.00813	CcSEcCtD
Mometasone—Arthralgia—Sorafenib—liver cancer	0.00538	0.00813	CcSEcCtD
Mometasone—Dermatitis contact—Epirubicin—liver cancer	0.00528	0.00798	CcSEcCtD
Mometasone—Dry mouth—Sorafenib—liver cancer	0.00526	0.00795	CcSEcCtD
Mometasone—CYP2C8—Tamoxifen metabolism—CYP2E1—liver cancer	0.00526	0.0158	CbGpPWpGaD
Mometasone—NR3C1—Nuclear Receptor transcription pathway—HNF4A—liver cancer	0.00525	0.0158	CbGpPWpGaD
Mometasone—Ulcer—Doxorubicin—liver cancer	0.00523	0.0079	CcSEcCtD
Mometasone—Influenza like illness—Epirubicin—liver cancer	0.00519	0.00784	CcSEcCtD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—NR1I3—liver cancer	0.00518	0.0155	CbGpPWpGaD
Mometasone—Anaphylactic shock—Sorafenib—liver cancer	0.00516	0.0078	CcSEcCtD
Mometasone—Infection—Sorafenib—liver cancer	0.00512	0.00774	CcSEcCtD
Mometasone—Candida infection—Epirubicin—liver cancer	0.0051	0.00771	CcSEcCtD
Mometasone—Musculoskeletal pain—Doxorubicin—liver cancer	0.005	0.00756	CcSEcCtD
Mometasone—Anorexia—Sorafenib—liver cancer	0.00492	0.00743	CcSEcCtD
Mometasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—liver cancer	0.00489	0.0147	CbGpPWpGaD
Mometasone—Dermatitis contact—Doxorubicin—liver cancer	0.00488	0.00738	CcSEcCtD
Mometasone—Influenza like illness—Doxorubicin—liver cancer	0.0048	0.00726	CcSEcCtD
Mometasone—Candida infection—Doxorubicin—liver cancer	0.00472	0.00713	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Sorafenib—liver cancer	0.0047	0.0071	CcSEcCtD
Mometasone—Dyspnoea—Sorafenib—liver cancer	0.0046	0.00695	CcSEcCtD
Mometasone—Dyspepsia—Sorafenib—liver cancer	0.00454	0.00686	CcSEcCtD
Mometasone—Decreased appetite—Sorafenib—liver cancer	0.00448	0.00678	CcSEcCtD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—liver cancer	0.00446	0.0134	CbGpPWpGaD
Mometasone—Fatigue—Sorafenib—liver cancer	0.00445	0.00672	CcSEcCtD
Mometasone—Pain—Sorafenib—liver cancer	0.00441	0.00667	CcSEcCtD
Mometasone—NR3C1—Adipogenesis—SCD—liver cancer	0.00432	0.013	CbGpPWpGaD
Mometasone—Gastrointestinal pain—Sorafenib—liver cancer	0.00422	0.00637	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—ATF3—liver cancer	0.00422	0.0127	CbGpPWpGaD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.00417	0.0125	CbGpPWpGaD
Mometasone—Body temperature increased—Sorafenib—liver cancer	0.00408	0.00616	CcSEcCtD
Mometasone—Abdominal pain—Sorafenib—liver cancer	0.00408	0.00616	CcSEcCtD
Mometasone—CYP2C8—Xenobiotics—CYP1A1—liver cancer	0.00393	0.0118	CbGpPWpGaD
Mometasone—CYP2C8—Tamoxifen metabolism—CYP1A1—liver cancer	0.00378	0.0113	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ATF3—liver cancer	0.00375	0.0113	CbGpPWpGaD
Mometasone—Asthenia—Sorafenib—liver cancer	0.0037	0.00559	CcSEcCtD
Mometasone—Pruritus—Sorafenib—liver cancer	0.00365	0.00552	CcSEcCtD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—HNF4A—liver cancer	0.00362	0.0109	CbGpPWpGaD
Mometasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—liver cancer	0.00356	0.0107	CbGpPWpGaD
Mometasone—Diarrhoea—Sorafenib—liver cancer	0.00353	0.00533	CcSEcCtD
Mometasone—NR3C1—Nuclear Receptors—PPARA—liver cancer	0.00349	0.0105	CbGpPWpGaD
Mometasone—Nasopharyngitis—Epirubicin—liver cancer	0.00347	0.00524	CcSEcCtD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.00338	0.0101	CbGpPWpGaD
Mometasone—Influenza—Epirubicin—liver cancer	0.00335	0.00507	CcSEcCtD
Mometasone—Asthma—Epirubicin—liver cancer	0.00335	0.00507	CcSEcCtD
Mometasone—Vomiting—Sorafenib—liver cancer	0.00328	0.00496	CcSEcCtD
Mometasone—Rash—Sorafenib—liver cancer	0.00325	0.00492	CcSEcCtD
Mometasone—Dermatitis—Sorafenib—liver cancer	0.00325	0.00491	CcSEcCtD
Mometasone—Headache—Sorafenib—liver cancer	0.00323	0.00488	CcSEcCtD
Mometasone—Bronchitis—Epirubicin—liver cancer	0.00322	0.00487	CcSEcCtD
Mometasone—CYP2C8—Arachidonic acid metabolism—HPGDS—liver cancer	0.00322	0.00968	CbGpPWpGaD
Mometasone—Nasopharyngitis—Doxorubicin—liver cancer	0.00321	0.00485	CcSEcCtD
Mometasone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—liver cancer	0.00316	0.00949	CbGpPWpGaD
Mometasone—NR3C1—Nuclear Receptors—ESR1—liver cancer	0.00316	0.00949	CbGpPWpGaD
Mometasone—Upper respiratory tract infection—Epirubicin—liver cancer	0.00311	0.00471	CcSEcCtD
Mometasone—Asthma—Doxorubicin—liver cancer	0.0031	0.00469	CcSEcCtD
Mometasone—Influenza—Doxorubicin—liver cancer	0.0031	0.00469	CcSEcCtD
Mometasone—CYP2C8—Biological oxidations—UGDH—liver cancer	0.00307	0.00923	CbGpPWpGaD
Mometasone—Nausea—Sorafenib—liver cancer	0.00306	0.00463	CcSEcCtD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—liver cancer	0.003	0.009	CbGpPWpGaD
Mometasone—Bronchitis—Doxorubicin—liver cancer	0.00298	0.00451	CcSEcCtD
Mometasone—Urinary tract infection—Epirubicin—liver cancer	0.0029	0.00439	CcSEcCtD
Mometasone—Conjunctivitis—Epirubicin—liver cancer	0.0029	0.00439	CcSEcCtD
Mometasone—NR3C1—Nuclear Receptors—PPARG—liver cancer	0.00288	0.00866	CbGpPWpGaD
Mometasone—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00288	0.00436	CcSEcCtD
Mometasone—Epistaxis—Epirubicin—liver cancer	0.00282	0.00426	CcSEcCtD
Mometasone—Sinusitis—Epirubicin—liver cancer	0.0028	0.00424	CcSEcCtD
Mometasone—NR3C1—Adipogenesis—AHR—liver cancer	0.00278	0.00836	CbGpPWpGaD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—liver cancer	0.00278	0.00834	CbGpPWpGaD
Mometasone—NR3C1—Nuclear Receptor transcription pathway—PPARA—liver cancer	0.00276	0.00828	CbGpPWpGaD
Mometasone—Rhinitis—Epirubicin—liver cancer	0.00269	0.00407	CcSEcCtD
Mometasone—Urinary tract infection—Doxorubicin—liver cancer	0.00269	0.00406	CcSEcCtD
Mometasone—Conjunctivitis—Doxorubicin—liver cancer	0.00269	0.00406	CcSEcCtD
Mometasone—Pharyngitis—Epirubicin—liver cancer	0.00266	0.00402	CcSEcCtD
Mometasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—liver cancer	0.00265	0.00797	CbGpPWpGaD
Mometasone—Epistaxis—Doxorubicin—liver cancer	0.00261	0.00394	CcSEcCtD
Mometasone—NR3C1—Circadian Clock—PPARA—liver cancer	0.00259	0.00779	CbGpPWpGaD
Mometasone—Sinusitis—Doxorubicin—liver cancer	0.00259	0.00392	CcSEcCtD
Mometasone—NR3C1—Nuclear Receptor transcription pathway—ESR1—liver cancer	0.0025	0.0075	CbGpPWpGaD
Mometasone—Rhinitis—Doxorubicin—liver cancer	0.00249	0.00376	CcSEcCtD
Mometasone—NR3C1—Regulation of Androgen receptor activity—MAPK14—liver cancer	0.00247	0.00741	CbGpPWpGaD
Mometasone—Pharyngitis—Doxorubicin—liver cancer	0.00246	0.00372	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—CSF2—liver cancer	0.00244	0.00733	CbGpPWpGaD
Mometasone—Immune system disorder—Epirubicin—liver cancer	0.00242	0.00366	CcSEcCtD
Mometasone—Mediastinal disorder—Epirubicin—liver cancer	0.00242	0.00365	CcSEcCtD
Mometasone—CYP2C8—Arachidonic acid metabolism—GGT1—liver cancer	0.00241	0.00725	CbGpPWpGaD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—TNF—liver cancer	0.00237	0.00712	CbGpPWpGaD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—liver cancer	0.0023	0.00692	CbGpPWpGaD
Mometasone—NR3C1—Nuclear Receptor transcription pathway—PPARG—liver cancer	0.00228	0.00684	CbGpPWpGaD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.00227	0.00682	CbGpPWpGaD
Mometasone—Back pain—Epirubicin—liver cancer	0.00226	0.00341	CcSEcCtD
Mometasone—Immune system disorder—Doxorubicin—liver cancer	0.00224	0.00339	CcSEcCtD
Mometasone—CYP2C8—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.00224	0.00673	CbGpPWpGaD
Mometasone—Mediastinal disorder—Doxorubicin—liver cancer	0.00224	0.00338	CcSEcCtD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—CSF2—liver cancer	0.00215	0.00646	CbGpPWpGaD
Mometasone—Back pain—Doxorubicin—liver cancer	0.00209	0.00316	CcSEcCtD
Mometasone—Cough—Epirubicin—liver cancer	0.00204	0.00308	CcSEcCtD
Mometasone—Arthralgia—Epirubicin—liver cancer	0.00199	0.00301	CcSEcCtD
Mometasone—Myalgia—Epirubicin—liver cancer	0.00199	0.00301	CcSEcCtD
Mometasone—Chest pain—Epirubicin—liver cancer	0.00199	0.00301	CcSEcCtD
Mometasone—Dry mouth—Epirubicin—liver cancer	0.00194	0.00294	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—ESR1—liver cancer	0.00194	0.00582	CbGpPWpGaD
Mometasone—NR3C1—Circadian Clock—SERPINE1—liver cancer	0.00193	0.0058	CbGpPWpGaD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—IL6—liver cancer	0.00191	0.00574	CbGpPWpGaD
Mometasone—Anaphylactic shock—Epirubicin—liver cancer	0.00191	0.00288	CcSEcCtD
Mometasone—Infection—Epirubicin—liver cancer	0.00189	0.00286	CcSEcCtD
Mometasone—CYP2C8—Arachidonic acid metabolism—CYP1A1—liver cancer	0.00189	0.00567	CbGpPWpGaD
Mometasone—Cough—Doxorubicin—liver cancer	0.00189	0.00285	CcSEcCtD
Mometasone—NR3C1—Endoderm Differentiation—APC—liver cancer	0.00187	0.00563	CbGpPWpGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.00184	0.00553	CbGpPWpGaD
Mometasone—Chest pain—Doxorubicin—liver cancer	0.00184	0.00278	CcSEcCtD
Mometasone—Myalgia—Doxorubicin—liver cancer	0.00184	0.00278	CcSEcCtD
Mometasone—Arthralgia—Doxorubicin—liver cancer	0.00184	0.00278	CcSEcCtD
Mometasone—Anorexia—Epirubicin—liver cancer	0.00182	0.00275	CcSEcCtD
Mometasone—Fluoxymesterone—ESR1—liver cancer	0.00181	0.324	CrCbGaD
Mometasone—Dry mouth—Doxorubicin—liver cancer	0.0018	0.00272	CcSEcCtD
Mometasone—CYP2C8—Biological oxidations—NR1H4—liver cancer	0.00179	0.00539	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—GSTA3—liver cancer	0.00176	0.0053	CbGpPWpGaD
Mometasone—Anaphylactic shock—Doxorubicin—liver cancer	0.00176	0.00267	CcSEcCtD
Mometasone—Infection—Doxorubicin—liver cancer	0.00175	0.00265	CcSEcCtD
Mometasone—Clobetasol propionate—CYP1A1—liver cancer	0.00175	0.314	CrCbGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—MAPK14—liver cancer	0.00174	0.00523	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—GSTA3—liver cancer	0.00174	0.00523	CbGpPWpGaD
Mometasone—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00174	0.00262	CcSEcCtD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—liver cancer	0.00172	0.00518	CbGpPWpGaD
Mometasone—Paraesthesia—Epirubicin—liver cancer	0.00171	0.00259	CcSEcCtD
Mometasone—Dyspnoea—Epirubicin—liver cancer	0.0017	0.00257	CcSEcCtD
Mometasone—Anorexia—Doxorubicin—liver cancer	0.00168	0.00254	CcSEcCtD
Mometasone—Dyspepsia—Epirubicin—liver cancer	0.00168	0.00254	CcSEcCtD
Mometasone—Decreased appetite—Epirubicin—liver cancer	0.00166	0.0025	CcSEcCtD
Mometasone—Fatigue—Epirubicin—liver cancer	0.00164	0.00248	CcSEcCtD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.00163	0.0049	CbGpPWpGaD
Mometasone—Pain—Epirubicin—liver cancer	0.00163	0.00246	CcSEcCtD
Mometasone—CYP2C8—Biological oxidations—GSTA4—liver cancer	0.00161	0.00485	CbGpPWpGaD
Mometasone—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.00161	0.00484	CbGpPWpGaD
Mometasone—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00161	0.00243	CcSEcCtD
Mometasone—CYP2C8—Metapathway biotransformation—GSTA4—liver cancer	0.00159	0.00478	CbGpPWpGaD
Mometasone—Paraesthesia—Doxorubicin—liver cancer	0.00158	0.00239	CcSEcCtD
Mometasone—CYP2C8—Biological oxidations—GSTA2—liver cancer	0.00157	0.00472	CbGpPWpGaD
Mometasone—Dyspnoea—Doxorubicin—liver cancer	0.00157	0.00238	CcSEcCtD
Mometasone—NR3C1—Regulation of Androgen receptor activity—JUN—liver cancer	0.00157	0.00471	CbGpPWpGaD
Mometasone—Gastrointestinal pain—Epirubicin—liver cancer	0.00156	0.00236	CcSEcCtD
Mometasone—Dyspepsia—Doxorubicin—liver cancer	0.00155	0.00235	CcSEcCtD
Mometasone—Decreased appetite—Doxorubicin—liver cancer	0.00153	0.00232	CcSEcCtD
Mometasone—Fatigue—Doxorubicin—liver cancer	0.00152	0.0023	CcSEcCtD
Mometasone—CYP2C8—Biological oxidations—GSTA1—liver cancer	0.00152	0.00456	CbGpPWpGaD
Mometasone—Pain—Doxorubicin—liver cancer	0.00151	0.00228	CcSEcCtD
Mometasone—Abdominal pain—Epirubicin—liver cancer	0.00151	0.00228	CcSEcCtD
Mometasone—Body temperature increased—Epirubicin—liver cancer	0.00151	0.00228	CcSEcCtD
Mometasone—CYP2C8—Biological oxidations—NAT2—liver cancer	0.0015	0.00451	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—CDKN2A—liver cancer	0.00149	0.00447	CbGpPWpGaD
Mometasone—NR3C1—Regulation of Androgen receptor activity—MAPK8—liver cancer	0.00148	0.00445	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—NAT2—liver cancer	0.00148	0.00444	CbGpPWpGaD
Mometasone—Gastrointestinal pain—Doxorubicin—liver cancer	0.00144	0.00218	CcSEcCtD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—liver cancer	0.00142	0.00426	CbGpPWpGaD
Mometasone—Abdominal pain—Doxorubicin—liver cancer	0.00139	0.00211	CcSEcCtD
Mometasone—Body temperature increased—Doxorubicin—liver cancer	0.00139	0.00211	CcSEcCtD
Mometasone—Asthenia—Epirubicin—liver cancer	0.00137	0.00207	CcSEcCtD
Mometasone—Pruritus—Epirubicin—liver cancer	0.00135	0.00204	CcSEcCtD
Mometasone—NR3C1—Generic Transcription Pathway—NR1H4—liver cancer	0.00133	0.00399	CbGpPWpGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.00132	0.00397	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—CDKN1B—liver cancer	0.00132	0.00396	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—NR1I3—liver cancer	0.00131	0.00393	CbGpPWpGaD
Mometasone—Diarrhoea—Epirubicin—liver cancer	0.0013	0.00197	CcSEcCtD
Mometasone—NR3C1—Adipogenesis—PPARA—liver cancer	0.0013	0.00392	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—IL2—liver cancer	0.00129	0.00387	CbGpPWpGaD
Mometasone—NR3C1—Endoderm Differentiation—CTNNB1—liver cancer	0.00127	0.00383	CbGpPWpGaD
Mometasone—Asthenia—Doxorubicin—liver cancer	0.00127	0.00191	CcSEcCtD
Mometasone—CYP2C8—Metapathway biotransformation—GPX3—liver cancer	0.00126	0.00378	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—CCND1—liver cancer	0.00126	0.00377	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—JUN—liver cancer	0.00125	0.00377	CbGpPWpGaD
Mometasone—Pruritus—Doxorubicin—liver cancer	0.00125	0.00189	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—CTNNB1—liver cancer	0.00124	0.00374	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—MMP9—liver cancer	0.00122	0.00366	CbGpPWpGaD
Mometasone—Vomiting—Epirubicin—liver cancer	0.00121	0.00183	CcSEcCtD
Mometasone—Diarrhoea—Doxorubicin—liver cancer	0.00121	0.00182	CcSEcCtD
Mometasone—Rash—Epirubicin—liver cancer	0.0012	0.00182	CcSEcCtD
Mometasone—Dermatitis—Epirubicin—liver cancer	0.0012	0.00181	CcSEcCtD
Mometasone—CYP2C8—Biological oxidations—HPGDS—liver cancer	0.0012	0.0036	CbGpPWpGaD
Mometasone—Headache—Epirubicin—liver cancer	0.00119	0.0018	CcSEcCtD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—IL2—liver cancer	0.00114	0.00341	CbGpPWpGaD
Mometasone—Nausea—Epirubicin—liver cancer	0.00113	0.00171	CcSEcCtD
Mometasone—Vomiting—Doxorubicin—liver cancer	0.00112	0.00169	CcSEcCtD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—liver cancer	0.00112	0.00335	CbGpPWpGaD
Mometasone—Rash—Doxorubicin—liver cancer	0.00111	0.00168	CcSEcCtD
Mometasone—Dermatitis—Doxorubicin—liver cancer	0.00111	0.00168	CcSEcCtD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.00111	0.00333	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—JUN—liver cancer	0.0011	0.00332	CbGpPWpGaD
Mometasone—Headache—Doxorubicin—liver cancer	0.0011	0.00167	CcSEcCtD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—liver cancer	0.00108	0.00325	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—PPARG—liver cancer	0.00108	0.00324	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—liver cancer	0.00107	0.00322	CbGpPWpGaD
Mometasone—Nausea—Doxorubicin—liver cancer	0.00105	0.00158	CcSEcCtD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—liver cancer	0.00105	0.00314	CbGpPWpGaD
Mometasone—NR3C1—Endoderm Differentiation—TGFB1—liver cancer	0.00103	0.00309	CbGpPWpGaD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—liver cancer	0.00101	0.00304	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—MYC—liver cancer	0.00101	0.00303	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—TGFB1—liver cancer	0.00101	0.00302	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—CYP2E1—liver cancer	0.000978	0.00294	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—SERPINE1—liver cancer	0.000971	0.00292	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—CYP2E1—liver cancer	0.000964	0.0029	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—HNF4A—liver cancer	0.000906	0.00272	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—GGT1—liver cancer	0.000898	0.0027	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—liver cancer	0.000897	0.00269	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—TP53—liver cancer	0.000828	0.00249	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—GSTP1—liver cancer	0.000806	0.00242	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—EXOSC2—liver cancer	0.000804	0.00242	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—GSTP1—liver cancer	0.000795	0.00239	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—CTNNB1—liver cancer	0.000758	0.00228	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—IL6—liver cancer	0.000758	0.00228	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—GSTM1—liver cancer	0.000741	0.00223	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—CDKN1A—liver cancer	0.000741	0.00223	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—GSTM1—liver cancer	0.000731	0.0022	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—liver cancer	0.000729	0.00219	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000715	0.00215	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—CYP1A1—liver cancer	0.000703	0.00211	CbGpPWpGaD
Mometasone—Prednisone—ALB—liver cancer	0.000694	0.125	CrCbGaD
Mometasone—CYP2C8—Metapathway biotransformation—CYP1A1—liver cancer	0.000693	0.00208	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000689	0.00207	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CASP3—liver cancer	0.00068	0.00204	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—liver cancer	0.000668	0.00201	CbGpPWpGaD
Mometasone—Dexamethasone—CYP2E1—liver cancer	0.000663	0.119	CrCbGaD
Mometasone—NR3C1—Adipogenesis—STAT3—liver cancer	0.000661	0.00199	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—JUN—liver cancer	0.00066	0.00198	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—liver cancer	0.000655	0.00197	CbGpPWpGaD
Mometasone—Dexamethasone—CYP1A1—liver cancer	0.000655	0.118	CrCbGaD
Mometasone—NR3C1—Gene Expression—NR1H4—liver cancer	0.00064	0.00192	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—NR1I3—liver cancer	0.000629	0.00189	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—liver cancer	0.000622	0.00187	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—liver cancer	0.000616	0.00185	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—TGFB1—liver cancer	0.000613	0.00184	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—liver cancer	0.000577	0.00173	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—TNF—liver cancer	0.000572	0.00172	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000527	0.00158	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—UGDH—liver cancer	0.000525	0.00158	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—TNF—liver cancer	0.000495	0.00149	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—EPT1—liver cancer	0.000494	0.00148	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—PPARA—liver cancer	0.000476	0.00143	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—TAT—liver cancer	0.000468	0.00141	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—IL6—liver cancer	0.000462	0.00139	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000461	0.00138	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—HNF4A—liver cancer	0.000436	0.00131	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—ESR1—liver cancer	0.000431	0.0013	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—IL6—liver cancer	0.000399	0.0012	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—PPARG—liver cancer	0.000393	0.00118	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—PSMD10—liver cancer	0.000381	0.00115	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—PSMA4—liver cancer	0.000381	0.00115	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—SERPINE1—liver cancer	0.000354	0.00106	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000345	0.00104	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GLUL—liver cancer	0.000318	0.000956	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CPT1B—liver cancer	0.000318	0.000956	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—NR1H4—liver cancer	0.000307	0.000922	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTA3—liver cancer	0.000302	0.000906	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTA4—liver cancer	0.000276	0.000829	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.00027	0.00081	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTA2—liver cancer	0.000269	0.000808	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTA1—liver cancer	0.00026	0.000779	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—H2AFX—liver cancer	0.000258	0.000774	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—NAT2—liver cancer	0.000257	0.000771	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000247	0.000741	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ALDOB—liver cancer	0.000246	0.000739	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CRABP1—liver cancer	0.000235	0.000705	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—PPARA—liver cancer	0.000229	0.000688	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—MYC—liver cancer	0.000224	0.000674	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—MAPK14—liver cancer	0.000212	0.000636	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000211	0.000635	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—ESR1—liver cancer	0.000208	0.000624	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—HPGDS—liver cancer	0.000205	0.000616	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000204	0.000613	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—PPARG—liver cancer	0.000189	0.000569	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000186	0.000558	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000183	0.000551	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PSMA4—liver cancer	0.000183	0.000549	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PSMD10—liver cancer	0.000183	0.000549	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GOT2—liver cancer	0.000178	0.000534	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—SERPINE1—liver cancer	0.000171	0.000513	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP2E1—liver cancer	0.000167	0.000502	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000162	0.000486	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYCS—liver cancer	0.000156	0.00047	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GOT1—liver cancer	0.000154	0.000461	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GGT1—liver cancer	0.000154	0.000461	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTP1—liver cancer	0.000138	0.000414	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—HMOX1—liver cancer	0.000136	0.000409	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTM1—liver cancer	0.000127	0.000381	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP1A1—liver cancer	0.00012	0.000361	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—MTHFR—liver cancer	0.000112	0.000336	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PPARA—liver cancer	0.00011	0.00033	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—MYC—liver cancer	0.000108	0.000324	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	9.87e-05	0.000296	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PIK3CG—liver cancer	9.41e-05	0.000283	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PPARG—liver cancer	9.08e-05	0.000273	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PIK3CD—liver cancer	8.27e-05	0.000248	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ALB—liver cancer	8.17e-05	0.000245	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—AKT1—liver cancer	7.49e-05	0.000225	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PIK3CB—liver cancer	7.21e-05	0.000217	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PIK3CA—liver cancer	4.4e-05	0.000132	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—AKT1—liver cancer	3.59e-05	0.000108	CbGpPWpGaD
